Literature DB >> 20928982

[Fifty years of clinical use of warfarin].

Jesús Alberto Quintero-González1.   

Abstract

Warfarin is the most utilized oral anticoagulant for the long term prophylaxes of thrombosis. Its use has been increased as new clinical conditions, capable of leading to thrombosis, have been detected. Due to the special characteristics of warfarin, such as the variability of doses for each individual, the narrow margin between adequate and inadequate doses, interaction with multiple pharmaceutical products, interference of its action by vitamin K present in the diet and the possibility of hemorrhagic complications or thrombotic recurrence, this drug requires a very careful dosage and strict laboratory and clinical monitoring. Despite being in the market for more than de fifty years and its many disadvantages, warfarin has not been substituted for the new oral anticoagulants. In 1999, warfarin was positioned eleventh on the list of the most used medicines in the world.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20928982

Source DB:  PubMed          Journal:  Invest Clin        ISSN: 0535-5133            Impact factor:   0.683


  3 in total

1.  Immediate and delayed traumatic intracranial hemorrhage in patients with head trauma and preinjury warfarin or clopidogrel use.

Authors:  Daniel K Nishijima; Steven R Offerman; Dustin W Ballard; David R Vinson; Uli K Chettipally; Adina S Rauchwerger; Mary E Reed; James F Holmes
Journal:  Ann Emerg Med       Date:  2012-06       Impact factor: 5.721

2.  Incidence of Delayed Intracranial Hemorrhage in Older Patients After Blunt Head Trauma.

Authors:  James A Chenoweth; Samuel D Gaona; Mark Faul; James F Holmes; Daniel K Nishijima
Journal:  JAMA Surg       Date:  2018-06-01       Impact factor: 14.766

Review 3.  Dabigatran: A new oral anticoagulant. Guidelines to follow in oral surgery procedures. A systematic review of the literature.

Authors:  M Muñoz-Corcuera; L Ramírez-Martínez-Acitores; R-M López-Pintor; E Casañas-Gil; G Hernández-Vallejo
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2016-11-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.